Form 483

Exelead, Inc. Form 483, 2011-06-07

FDA issued a Form 483 to Exelead, Inc. on 2011-06-07 with 4 public-safe observations.

483· Form 483 issued4 observations

Exelead, Inc. · Indianapolis, United States · Issued June 7, 2011

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Jun 2011
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Robert M Barbosa

7 Jun 2011
21 CFR 211.63

Equipment Design, Size and Location

Cited by Robert M Barbosa

7 Jun 2011
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Robert M Barbosa

7 Jun 2011
21 CFR 211.166(a)

Results not used for expiration dates, storage cond.

Cited by Robert M Barbosa

Inspected site

EIExelead, Inc.Indianapolis, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere